Healthcare stocks take a hit after Trump order

Amy Baxter | | Health Exec | Policy & Regulations
Stocks

Healthcare stocks are reeling following an executive order from President Trump that would give HHS the ability to require hospitals and health insurance companies to provide patients with prices for healthcare services based on negotiated rates. The idea is to make healthcare more “shoppable,” but healthcare providers are not enthused by the idea.

Stocks of major healthcare insurers, including UnitedHealth Group, Humana, Cigna and Anthem all fell in the aftermath of the news, according to Zacks. Hospital stocks, including Community Health Systems and Tenet Healthcare, took bigger hits, with drops of 5.17% and 2.57%, respectively, on Tuesday.

The administration has already finalized a new requirement to make drugmakers publish the list prices of pharmaceuticals in TV advertisements, but most patients with health insurance end up paying negotiated prices.

See the full story below:

Healthcare Tumbles on Trump's Price Disclosure Order

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Report: 44% of adults in the U.S. are uninsured or underinsured
Texas AG sues hospital for $10K after off-duty police barred from carrying guns
Cardiologists reflect on developing primary PCI in face of criticism and pushback
PBMs sue FTC for alleged Fifth Amendment violation
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”